Form 4 for SKIN SkinHealth Systems Inc.
Accepted 2023-12-01 00:00:00 ET · period of report 2023-11-29 · accession 0001628280-23-040452 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-01 | 2023-11-29 | SKIN | Watson Daniel Copell | Chief Revenue Oficer | A - Grant | — | +156.2K | 565.1K | +38% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-11-29 | A | A | 156,250 | — | 565,114 | D | — | — | (F1) Represents a retention award of restricted stock units (the "RSUs"). Fifty percent (50%) of the RSUs will vest on December 1, 2024, and the remaining fifty percent (50%) of the RSUs will vest on June 1, 2025, in each case subject to continued service through the applicable vesting date and certain acceleration rights. |